Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
CT1812
https://alzheimersnewstoday.com/ct1812/
links
backlinks
CT1812 is an oral medication being developed by Cognition Therapeutics, now in clinical testing, to possibly treat mild-to-moderate Alzheimer’s disease by preventing the build up of beta-amyloid in the brain.
Roast topics
Find topics
Find it!
